Saints Capital

Saints Advisors, LLC is a boutique investment firm based in San Francisco, California, specializing in financial advisory services such as mergers and acquisitions, capital raising, and corporate restructuring, primarily within the technology and healthcare sectors. Saints Capital, a merchant venture capital firm also headquartered in San Francisco, operates with a focus on direct secondary acquisitions of venture capital and private equity investments in emerging growth companies. Additionally, Saints Capital engages in traditional direct venture capital investments in technology, healthcare, consumer, and industrial sectors across North America, Europe, and Asia-Pacific. The firm manages several venture capital funds, including Saints Capital Falcon, Everest, and Ventures II, each targeting specific industries like software, healthcare devices, life sciences, and technology, media, and telecommunications.

Spencer Clark

Associate

Robert Keppler

CFO

Leslie Montag

Associate

David Quinlivan

Co-Founder and Managing Director

72 past transactions

Equalum

Series C in 2022
Equalum Ltd. is a company that specializes in developing a data-beaming platform for real-time data ingestion and processing, primarily aimed at enterprises dealing with Big Data. Founded in 2015 and headquartered in Tel Aviv, Israel, Equalum's platform enables the seamless transport of data from various sources, such as message queues, sensors, files, applications, and databases, to cloud services and analytics platforms. Its user-friendly interface features drag-and-drop functionality, along with robust data replication and streaming ETL tools, facilitating the rapid creation of real-time data pipelines with minimal coding required. Equalum’s solutions are utilized by Fortune 500 and mid-sized companies across diverse industries, enhancing capabilities in data warehouse modernization, real-time analytics, and artificial intelligence/machine learning applications. The platform is built on industry-leading change data capture technology, allowing businesses to efficiently process and transform data as it is generated.

Xage Security

Series B in 2022
Xage Security, Inc. specializes in providing a blockchain-protected security platform tailored for industrial IoT (Internet of Things). Their product offerings include the Xage Gateway, which connects to various IIoT edge devices for authentication and enforcement, and the Xage Broker, which manages credentials and data synchronization between edge and central systems. Additionally, the Xage Client Agent facilitates direct participation in the Xage Blockchain-secured ecosystem, while the Xage Security Cloud enables configuration and monitoring of the entire suite. The company emphasizes solutions such as tamper proofing, edge authentication, role-based access control, and device lifecycle management. Founded in 2016 and headquartered in Palo Alto, California, Xage Security serves a wide range of industries, including energy, transportation, utilities, manufacturing, and healthcare, focusing on zero trust access and protection to secure critical assets against advanced threats.

Minerva Networks

Secondary Market in 2017
Minerva Networks is a provider of carrier-grade IPTV service management software, specializing in video networking and management solutions. The company offers an open platform that enables telecommunications, cable, satellite operators, internet service providers, and broadcasters to deliver a comprehensive array of video services over broadband Internet Protocol (IP) networks. Their platform supports features such as live television, video-on-demand, and electronic program guides, along with blended internet and television capabilities. Additionally, Minerva Networks provides a suite of professional services to assist in the deployment of end-to-end video networking solutions, ensuring that subscribers can access an enhanced entertainment experience on any device and across various networks at any time.

Direct Flow Medical

Series C in 2016
Direct Flow Medical is a medical device company focused on developing innovative transcatheter aortic valve replacement systems aimed at treating cardiac valve insufficiency. The company’s flagship product is a percutaneous aortic tissue valve prosthesis designed to offer a safe and effective alternative for patients, particularly those over the age of 65 who suffer from calcified aortic valves. Despite the prevalence of this condition, with approximately 1.2 million affected individuals, only around 150,000 receive surgical treatment annually. Direct Flow Medical's technology enhances patient outcomes and minimizes complications by allowing heart surgeons to perform valve replacements without invasive surgery, using repeated assessments of hemodynamic performance prior to final implantation.

Actelis Networks

Venture Round in 2016
Actelis Networks, Inc. specializes in high-performance broadband solutions over copper, enabling the delivery of Ethernet and broadband access services. Founded in 1998 and headquartered in Fremont, California, the company offers a range of products, including aggregation switches, Ethernet access devices, and various broadband amplifiers. Its solutions cater to service operators and government customers, addressing needs in residential broadband, business Ethernet, small cell and Wi-Fi backhaul, as well as intelligent traffic systems and municipal networks. Actelis Networks effectively transforms copper infrastructure into a strategic asset, facilitating reliable and cost-effective connectivity for Internet of Things (IoT) projects across diverse environments such as cities, campuses, and military bases. The company emphasizes security in its networking solutions, ensuring protection for critical IoT data through advanced coding and encryption technologies. Actelis distributes its products via a network of resellers and maintains research and development facilities in Tel Aviv, alongside regional sales offices globally.

InnFocus

Series C in 2015
InnFocus is a biomaterials company, develops and provides products in ophthalmology. The company's product portfolio includes an intraocular lens for microincision surgery and an implantable device for glaucoma. The company was incorporated in 2003 and is based in Miami, Florida.

eBags.com

Venture Round in 2015
eBags, Inc. is a prominent online retailer specializing in a diverse range of bags and travel accessories catering to various lifestyles. Founded in 1999 and based in Greenwood Village, Colorado, eBags offers an extensive selection of products, including luggage, travel bags, handbags, backpacks, and fashion accessories such as cosmetic bags and wallets. The company features products for all demographics, including men, women, and children, and provides items designed for travel, fitness, and outdoor activities. eBags partners with well-known brands like Samsonite, JanSport, and The North Face, ensuring a broad selection of premium products. Committed to exceptional customer service, eBags offers personalized assistance and real-time order tracking to enhance the shopping experience. As of 2017, eBags operates as a subsidiary of Samsonite LLC.

OraMetrix

Debt Financing in 2015
OraMetrix, Inc. provides 3-D technology solutions for facilitating and improving the quality of orthodontic care. It offers an orthodontic treatment system that allows the use of precision digital tools throughout the diagnosis, treatment planning and monitoring, and arch wire customization processes of the orthodontic treatment. OraMetrix, Inc. was formerly known as Orthotel, Inc. The company was founded in 1998 and is based in Richardson, Texas with an additional office in Berlin, Germany.

Kona Medical

Debt Financing in 2015
Kona Medical, Inc. is a medical technology company founded in 2009 and based in Issaquah, Washington. It specializes in the development of a non-invasive ultrasound-based therapy system aimed at treating hypertension, particularly in patients with drug-resistant hypertension. The company's flagship product, Surround Sound, utilizes ultrasound imaging to precisely guide the application of focused ultrasound energy for renal denervation, targeting the nerves connected to the kidneys to help regulate blood pressure. By offering a less invasive alternative to traditional treatments, Kona Medical seeks to address the health risks associated with high blood pressure while improving patient outcomes through advanced therapeutic techniques.

Cianna Medical

Venture Round in 2015
Cianna Medical, Inc. is a women’s health company focused on innovative solutions for the treatment of early-stage breast cancer. Based in Aliso Viejo, California, the company develops advanced medical technologies designed to enhance breast conservation therapy. Its primary products include SAVI SCOUT, a wire-free radar localization system that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation therapy to minimize damage to surrounding healthy tissue. Additionally, Cianna Medical provides BrachyBytes, an e-newsletter that shares insights and expert interviews on breast brachytherapy. Incorporated in 2007, the company aims to expand access to effective treatment options for women diagnosed with breast cancer, improving their chances for successful outcomes. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.

VisionSense

Debt Financing in 2015
VisionSense develops innovative visualization solutions designed to enhance minimally invasive surgery (MIS). By utilizing advanced sensor technology and proprietary software, the VisionSense system provides surgeons with stereoscopic sight, delivering depth perception and high-definition 3D images through the smallest access points. Unlike traditional MIS vision solutions that offer only 2D images, VisionSense's technology significantly improves a surgeon's perspective by enabling better tissue understanding and hand-eye coordination. This enhancement allows for the confident use of advanced articulating surgical tools, ultimately facilitating more complex surgical procedures.

Gilt Groupe

Series F in 2015
Gilt Groupe is an online retail platform based in New York City that specializes in luxury goods. It offers a wide selection of merchandise, including fashion for men, women, and children, as well as home decor and unique experiences in select cities. The company provides clothing, shoes, and accessories for men, and a diverse range of products for women, including handbags, jewelry, watches, health and beauty items, and maternity wear. For children, Gilt Groupe features clothing, toys, books, and home essentials, while its home category includes furniture, bedding, decor, and kitchen products. Founded in 2007 by Alexandra Wilkis Wilson, Alexis Maybank, and others, Gilt Groupe operates as a subsidiary of Hudson's Bay Company since February 2016, focusing on delivering an accessible and streamlined shopping experience for luxury lifestyle brands.

OrSense

Series H in 2015
OrSense Ltd. is a medical device company based in Petah-Tikva, Israel, specializing in non-invasive monitoring technologies for blood parameter measurement. Founded in 1996, the company develops solutions that enable continuous monitoring of hemoglobin, oxygen saturation, and pulse rate, utilizing its proprietary Occlusion Spectroscopy technology. The flagship product, the NBM 200MP system, allows for non-invasive measurement of multiple blood parameters, including hemoglobin, hematocrit, and low perfusion oximetry, making it suitable for use in hospitals, outpatient settings, and emergency services. OrSense's products have received CE approval and have been validated through testing on over 4,000 patients across various clinical environments in the U.S. and Europe. Their innovative approach addresses challenges such as poor peripheral perfusion and motion-induced noise, providing reliable and accurate monitoring solutions for healthcare providers.

MedVantx

Debt Financing in 2014
MedVantx, based in San Diego, California, is a consumer medication management and delivery company focused on reducing costs and improving access to medications for patients, healthcare providers, payors, employers, and manufacturers. The company operates a licensed mail order pharmacy in Sioux Falls, South Dakota, which serves as a comprehensive provider of prescription drugs and related information across all 50 states. Their 35,000 square foot facility has undergone significant upgrades to meet over 200 cGMP-level quality standards and is equipped to handle pharmaceuticals requiring Cold Chain processing. MedVantx has developed a direct-to-patient platform that facilitates closer connections between pharmaceutical manufacturers and patients, streamlining delivery, minimizing costs, and enhancing the user experience by allowing patients to receive medications without visiting retail pharmacies. Recognized by Inc. Magazine in 2009 as the fastest growing privately held healthcare company in the United States, MedVantx continues to innovate in the medication delivery space.

VisionCare Ophthalmic Technologies

Venture Round in 2014
VisionCare Ophthalmic Technologies, Inc. is a specialty medical device company based in Saratoga, California, focused on the research, development, manufacture, and marketing of innovative implantable ophthalmic devices. The company primarily aims to enhance vision and quality of life for individuals suffering from untreatable retinal disorders, particularly end-stage age-related macular degeneration (AMD), which is a leading cause of blindness among older Americans. VisionCare's flagship product is the Implantable Miniature Telescope, the first FDA-approved device designed to improve vision in patients with advanced AMD. This telescope implant is a critical component of the CentraSight treatment program, which guides patients through the processes of diagnosis, surgical evaluation, and postoperative care. Founded in 1997, VisionCare is dedicated to helping patients reconnect with their daily lives and activities through its advanced visual prosthetic technologies.

VaxInnate

Venture Round in 2014
VaxInnate is a biotechnology company based in Cranbury, New Jersey, founded in 2002. The company specializes in developing vaccines aimed at combating diseases such as influenza, malaria, dengue, papillomavirus, and respiratory syncytial virus. VaxInnate employs a unique approach by genetically fusing vaccine antigens with bacterial protein flagellin, which enhances the immunogenicity and efficacy of the vaccines. This innovative method facilitates quicker patient treatment initiation and increases the likelihood of successful outcomes. Through its focus on healthcare and health diagnostics, VaxInnate aims to address significant public health challenges with its advanced vaccine solutions.

InnoPath

Debt Financing in 2014
InnoPath specializes in mobile device management services, offering software solutions that enable wireless operators and device manufacturers to manage mobile devices effectively. The company's technology facilitates over-the-air updates, diagnostics, and repairs, allowing operators to remotely connect, configure, troubleshoot, and secure user devices. By utilizing InnoPath's solutions, clients can avoid device recalls and returns, decrease the number of support calls, enhance first call resolution for issues related to Android and iOS devices, and ultimately increase subscriber satisfaction.

Vidyo

Series E in 2014
Vidyo, Inc. specializes in high-definition video conferencing software that facilitates universal visual communication. Its suite of products includes VidyoDesktop, which allows users on Windows, Mac, and Linux to engage in video conferences from various locations, and VidyoWeb, a browser extension enabling conference participation from desktop and laptop computers. Additionally, VidyoRoom Solutions offer tailored in-office video conferencing experiences for hybrid teams, while VidyoMobile provides high-quality conferencing capabilities for mobile devices. VidyoSlate allows users to share and annotate content during conferences. The company serves diverse sectors including healthcare, education, government, and enterprise, emphasizing the importance of video communication in enhancing productivity and collaboration. Founded in 2005 and headquartered in Hackensack, New Jersey, Vidyo has expanded its presence worldwide with offices in multiple countries. As of 2019, it operates as a subsidiary of Enghouse Systems Limited.

Circadence

Debt Financing in 2014
Circadence Corporation is a leading developer of products and solutions designed to optimize network infrastructure and enhance cybersecurity readiness. Founded in 1993 and based in Boulder, Colorado, with additional offices in Tupelo, Mississippi, McLean, Virginia, and Littleton, Colorado, the company offers a range of products, including the MVO 1200 WAN Optimization suite, which improves application performance and user experience. Circadence also provides a suite of MVO appliances for managing remote network connections and various cybersecurity training solutions, including cyber range design and development, and a cybersecurity awareness learning platform known as inCyt. Catering to enterprises, healthcare, oil and gas sectors, small and medium businesses, public sector organizations, and government entities, Circadence emphasizes innovative and immersive training experiences that adapt to evolving cyber threats. The company is recognized as a Microsoft Gold Partner, reflecting its commitment to delivering cutting-edge cybersecurity solutions.

MBlox

Debt Financing in 2014
Founded in 1999, Mblox is a leading provider of mobile messaging and payment solutions, specializing in Application-to-Person communication. The company has established over 100 direct relationships with mobile carriers worldwide, making it a trusted partner for businesses needing reliable mobile messaging services. Mblox processes approximately 7 billion messages annually for over 4,000 clients, ranging from small startups to large multinational corporations. Their cloud-based platform is designed to meet the diverse needs of various industries, including financial services, government, transportation, logistics, retail, and advertising. Mblox is committed to customer service, offering 24/7 email support through an in-house team of experts, along with tailored support packages to accommodate different business requirements.

Mitralign

Venture Round in 2014
Mitralign is a privately held company based in a suburb of Boston, Massachusetts, focused on developing a catheter-based technology for the treatment of functional mitral regurgitation. The company has created an innovative system that mimics surgical annuloplasty by delivering surgical implants directly into the mitral annulus via a catheter. This process involves cinching the implants together to decrease the size of the mitral valve annulus and the valve opening. Mitralign's technology aims to provide a less invasive option for managing this life-threatening cardiac condition, enabling healthcare providers to effectively treat symptomatic functional mitral regurgitation through tissue-plication. The company is supported by prominent venture capitalists and has attracted investments from major cardiovascular device firms.

Arcadia Biosciences

Series D in 2014
Arcadia Biosciences, Inc. is an agricultural technology company based in Davis, California, focusing on the development of crop productivity traits primarily in hemp, wheat, and soybean. Established in 2002, the company employs advanced screening, breeding, and biotechnology techniques to create products that enhance farm economics and improve the value of crops as food ingredients, health and wellness products, and for industrial applications. Its product lineup includes GoodHemp, a range of non-GMO hemp seed varieties aimed at genetic improvement; GoodWheat, which transforms wheat into a functional food; and a drought and herbicide-tolerant soybean trait known as HB4. Additionally, Arcadia Biosciences produces plant-based food and beverage products, including high-fiber pasta and coconut water, thereby catering to consumer demands while promoting environmental sustainability. The company operates in diverse markets, including the United States, Canada, Africa, and India, and collaborates with several industry partners to advance its initiatives.

OrSense

Series H in 2014
OrSense Ltd. is a medical device company based in Petah-Tikva, Israel, specializing in non-invasive monitoring technologies for blood parameter measurement. Founded in 1996, the company develops solutions that enable continuous monitoring of hemoglobin, oxygen saturation, and pulse rate, utilizing its proprietary Occlusion Spectroscopy technology. The flagship product, the NBM 200MP system, allows for non-invasive measurement of multiple blood parameters, including hemoglobin, hematocrit, and low perfusion oximetry, making it suitable for use in hospitals, outpatient settings, and emergency services. OrSense's products have received CE approval and have been validated through testing on over 4,000 patients across various clinical environments in the U.S. and Europe. Their innovative approach addresses challenges such as poor peripheral perfusion and motion-induced noise, providing reliable and accurate monitoring solutions for healthcare providers.

Transonic Combustion

Debt Financing in 2014
Transonic Combustion, founded in 2006 and headquartered in Camarillo, California, specializes in advanced fuel injection systems designed to enhance the efficiency of modern automotive engines. The company's TSCi™ fuel delivery technology is tailored for global automotive manufacturers, aiming to improve fuel efficiency and performance in various engine platforms. Transonic Combustion is backed by notable venture capital firms, including Venrock, Khosla Ventures, Rustic Canyon, and Saints Capital, indicating strong investor confidence in its innovative approach to fuel technology.

VisionSense

Series E in 2014
VisionSense develops innovative visualization solutions designed to enhance minimally invasive surgery (MIS). By utilizing advanced sensor technology and proprietary software, the VisionSense system provides surgeons with stereoscopic sight, delivering depth perception and high-definition 3D images through the smallest access points. Unlike traditional MIS vision solutions that offer only 2D images, VisionSense's technology significantly improves a surgeon's perspective by enabling better tissue understanding and hand-eye coordination. This enhancement allows for the confident use of advanced articulating surgical tools, ultimately facilitating more complex surgical procedures.

Actelis Networks

Debt Financing in 2014
Actelis Networks, Inc. specializes in high-performance broadband solutions over copper, enabling the delivery of Ethernet and broadband access services. Founded in 1998 and headquartered in Fremont, California, the company offers a range of products, including aggregation switches, Ethernet access devices, and various broadband amplifiers. Its solutions cater to service operators and government customers, addressing needs in residential broadband, business Ethernet, small cell and Wi-Fi backhaul, as well as intelligent traffic systems and municipal networks. Actelis Networks effectively transforms copper infrastructure into a strategic asset, facilitating reliable and cost-effective connectivity for Internet of Things (IoT) projects across diverse environments such as cities, campuses, and military bases. The company emphasizes security in its networking solutions, ensuring protection for critical IoT data through advanced coding and encryption technologies. Actelis distributes its products via a network of resellers and maintains research and development facilities in Tel Aviv, alongside regional sales offices globally.

Xtime

Venture Round in 2014
Xtime is a prominent provider of hosted Customer Relationship Management (CRM) and scheduling software specifically designed for automotive service departments in North America. The company serves over 3,000 dealerships and manages more than 1 million customer appointments monthly. Xtime is recognized as the exclusive or preferred software provider for several leading global automotive manufacturers, including Lexus, Toyota, BMW, and Mercedes-Benz. Additionally, it is a trusted partner for major dealership groups such as AutoNation and Group 1 Automotive. Headquartered in Redwood Shores, California, Xtime's software integrates various functions across marketing, sales, service, and operations, ensuring a cohesive experience that meets consumer demands in the automotive sector.

NComputing

Debt Financing in 2014
NComputing, Inc. is a provider of client virtualization solutions based in Santa Clara, California, founded in 2003. The company specializes in enabling users to access personalized desktops, applications, and data from any device and location, leveraging its advanced technology platform. This platform incorporates UXP transmission protocols, a virtualization server, application awareness, and thin client devices, allowing NComputing to deliver low-cost computing solutions tailored for various sectors, including education, healthcare, finance, manufacturing, and government. With approximately 4 million seats installed across more than 60,000 customers, NComputing focuses on simplicity, performance, and value, serving both larger enterprises and small to medium-sized businesses.

OrSense

Debt Financing in 2014
OrSense Ltd. is a medical device company based in Petah-Tikva, Israel, specializing in non-invasive monitoring technologies for blood parameter measurement. Founded in 1996, the company develops solutions that enable continuous monitoring of hemoglobin, oxygen saturation, and pulse rate, utilizing its proprietary Occlusion Spectroscopy technology. The flagship product, the NBM 200MP system, allows for non-invasive measurement of multiple blood parameters, including hemoglobin, hematocrit, and low perfusion oximetry, making it suitable for use in hospitals, outpatient settings, and emergency services. OrSense's products have received CE approval and have been validated through testing on over 4,000 patients across various clinical environments in the U.S. and Europe. Their innovative approach addresses challenges such as poor peripheral perfusion and motion-induced noise, providing reliable and accurate monitoring solutions for healthcare providers.

BioSET

Debt Financing in 2014
BioSET, Inc. specializes in the research and development of synthetic bioactive peptides aimed at enhancing bone and soft tissue repair. The company offers a range of medical devices, including AMPLEX, an implantable combination device designed for surgical bone graft applications in spine fusion and other orthopedic procedures. BioSET's product portfolio also includes innovations for sports medicine, peptide signaling molecules, and various scaffold biomaterials, all intended for use in musculoskeletal applications such as trauma, fracture repair, and soft tissue treatments. Founded in 2001 and based in Rockville, Maryland, BioSET operates as a subsidiary of Ferring Pharmaceuticals Inc.

Vidyo

Series D in 2013
Vidyo, Inc. specializes in high-definition video conferencing software that facilitates universal visual communication. Its suite of products includes VidyoDesktop, which allows users on Windows, Mac, and Linux to engage in video conferences from various locations, and VidyoWeb, a browser extension enabling conference participation from desktop and laptop computers. Additionally, VidyoRoom Solutions offer tailored in-office video conferencing experiences for hybrid teams, while VidyoMobile provides high-quality conferencing capabilities for mobile devices. VidyoSlate allows users to share and annotate content during conferences. The company serves diverse sectors including healthcare, education, government, and enterprise, emphasizing the importance of video communication in enhancing productivity and collaboration. Founded in 2005 and headquartered in Hackensack, New Jersey, Vidyo has expanded its presence worldwide with offices in multiple countries. As of 2019, it operates as a subsidiary of Enghouse Systems Limited.

Art.com

Series C in 2013
Art.com is an online platform specializing in the sale of wall art and decorative items, founded in 1998 and headquartered in San Bruno, California. The company offers a diverse range of products, including high-quality wall art, limited-edition prints, hand-painted originals, and home accessories. It serves a wide array of customers, including retail partners, museums, hotels, and interior designers, providing them with innovative art solutions to enhance their spaces. Art.com aims to facilitate exploration and expression through art, catering to individuals seeking to personalize their environments.

Xtime

Venture Round in 2012
Xtime is a prominent provider of hosted Customer Relationship Management (CRM) and scheduling software specifically designed for automotive service departments in North America. The company serves over 3,000 dealerships and manages more than 1 million customer appointments monthly. Xtime is recognized as the exclusive or preferred software provider for several leading global automotive manufacturers, including Lexus, Toyota, BMW, and Mercedes-Benz. Additionally, it is a trusted partner for major dealership groups such as AutoNation and Group 1 Automotive. Headquartered in Redwood Shores, California, Xtime's software integrates various functions across marketing, sales, service, and operations, ensuring a cohesive experience that meets consumer demands in the automotive sector.

Transonic Combustion

Series D in 2012
Transonic Combustion, founded in 2006 and headquartered in Camarillo, California, specializes in advanced fuel injection systems designed to enhance the efficiency of modern automotive engines. The company's TSCi™ fuel delivery technology is tailored for global automotive manufacturers, aiming to improve fuel efficiency and performance in various engine platforms. Transonic Combustion is backed by notable venture capital firms, including Venrock, Khosla Ventures, Rustic Canyon, and Saints Capital, indicating strong investor confidence in its innovative approach to fuel technology.

Mitralign

Series D in 2012
Mitralign is a privately held company based in a suburb of Boston, Massachusetts, focused on developing a catheter-based technology for the treatment of functional mitral regurgitation. The company has created an innovative system that mimics surgical annuloplasty by delivering surgical implants directly into the mitral annulus via a catheter. This process involves cinching the implants together to decrease the size of the mitral valve annulus and the valve opening. Mitralign's technology aims to provide a less invasive option for managing this life-threatening cardiac condition, enabling healthcare providers to effectively treat symptomatic functional mitral regurgitation through tissue-plication. The company is supported by prominent venture capitalists and has attracted investments from major cardiovascular device firms.

Cellomics Technology

Seed Round in 2012
Cellomics Technology LLC is a biotechnology company based in the Biotech Corridor of the Nation’s Capital, specializing in gene targeting in mammalian cells. The company provides a range of products and services tailored for academic, biotechnology, and pharmaceutical research needs. It focuses on lentiviral vector production, offering a variety of pre-made lentiviral vectors to facilitate gene targeting projects. Additionally, Cellomics Technology develops tools for genetic engineering of somatic and stem cells, and provides licensed professional services to address specific custom research requirements. Through these offerings, the company aims to support and accelerate advancements in genetic research.

Solace Therapeutics

Venture Round in 2012
Solace Therapeutics, Inc. is a medical device company focused on developing non-surgical treatments for common bladder disorders, including stress urinary incontinence, overactive bladder, male voiding dysfunction, and lower urinary tract symptoms. The company offers the Vesair Bladder Control System, a lightweight device designed to float within the urinary bladder and effectively reduce involuntary urinary leakage. Solace Therapeutics aims to enhance patient quality of life by providing an office-based therapy that avoids the side effects often associated with traditional drug and surgical options. This innovative approach does not require anesthesia or significant lifestyle changes and is reversible at any time. Established in 2002, Solace Therapeutics is headquartered in Framingham, Massachusetts.

Radius Health

Private Equity Round in 2011
Radius Health, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions for osteoporosis and oncology. The company markets TYMLOS, an anabolic agent specifically for postmenopausal women with osteoporosis. It is advancing several clinical programs, including abaloparatide-SC, currently in phase 3 trials for treating osteoporosis in men, and a short-wear-time transdermal patch for postmenopausal women. Additionally, Radius is developing Elacestrant, a selective estrogen receptor degrader in phase 3 studies for hormone receptor-positive breast cancer, and RAD140, a selective androgen receptor modulator in phase 1A trials for metastatic breast cancer. Founded in 2003 and based in Waltham, Massachusetts, Radius Health collaborates with various organizations, including 3M Company and Duke University, to enhance its research and development efforts in bone health and women's health issues.

CircuLite

Series D in 2011
CircuLite is a cardiovascular device company focused on transforming the treatment of heart failure through the development of minimally-invasive micro-pumps designed for long-term partial circulatory support. Its innovative approach allows for a proactive and lower-risk treatment option that enhances a patient's natural heart function, potentially improving the quality of life for millions of individuals with chronic heart failure. The company's proprietary micro-pump platform enables these devices to be small enough for implantation in a manner similar to pacemakers, utilizing endovascular or minimally-invasive surgical techniques. CircuLite's technology aims to provide essential support for patients with failing hearts by supplementing their natural pumping capacity.

Radius Health

Series C in 2011
Radius Health, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions for osteoporosis and oncology. The company markets TYMLOS, an anabolic agent specifically for postmenopausal women with osteoporosis. It is advancing several clinical programs, including abaloparatide-SC, currently in phase 3 trials for treating osteoporosis in men, and a short-wear-time transdermal patch for postmenopausal women. Additionally, Radius is developing Elacestrant, a selective estrogen receptor degrader in phase 3 studies for hormone receptor-positive breast cancer, and RAD140, a selective androgen receptor modulator in phase 1A trials for metastatic breast cancer. Founded in 2003 and based in Waltham, Massachusetts, Radius Health collaborates with various organizations, including 3M Company and Duke University, to enhance its research and development efforts in bone health and women's health issues.

Cianna Medical

Series B in 2011
Cianna Medical, Inc. is a women’s health company focused on innovative solutions for the treatment of early-stage breast cancer. Based in Aliso Viejo, California, the company develops advanced medical technologies designed to enhance breast conservation therapy. Its primary products include SAVI SCOUT, a wire-free radar localization system that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation therapy to minimize damage to surrounding healthy tissue. Additionally, Cianna Medical provides BrachyBytes, an e-newsletter that shares insights and expert interviews on breast brachytherapy. Incorporated in 2007, the company aims to expand access to effective treatment options for women diagnosed with breast cancer, improving their chances for successful outcomes. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.

AngioScore

Venture Round in 2011
AngioScore Inc. is engaged in the development, manufacturing, and marketing of medical devices, specifically focusing on the AngioSculpt Scoring Balloon Catheter. This catheter is designed for use in both coronary and peripheral interventional markets, addressing the limitations commonly associated with traditional angioplasty balloon catheters. The AngioSculpt features a semi-compliant balloon combined with a unique nitinol scoring element, enhancing its effectiveness in endovascular therapy. The company's products are aimed at improving the treatment of cardiovascular and vascular diseases.

Capella

Venture Round in 2011
Capella specializes in wavelength selective switch (WSS) technology, primarily for applications in reconfigurable optical add/drop multiplexers (ROADM) and optical cross connects (OXC). The company's advanced intelligent subsystems are designed to enhance wavelength management, offering dynamic and remote reconfigurability. Capella's products integrate optical channel monitoring, which is crucial for the performance and efficiency of next-generation ROADM systems. By focusing on these technologies, Capella positions itself as a leader in the optical networking industry, providing essential solutions that streamline operations for its users.

VisionCare Ophthalmic Technologies

Series E in 2011
VisionCare Ophthalmic Technologies, Inc. is a specialty medical device company based in Saratoga, California, focused on the research, development, manufacture, and marketing of innovative implantable ophthalmic devices. The company primarily aims to enhance vision and quality of life for individuals suffering from untreatable retinal disorders, particularly end-stage age-related macular degeneration (AMD), which is a leading cause of blindness among older Americans. VisionCare's flagship product is the Implantable Miniature Telescope, the first FDA-approved device designed to improve vision in patients with advanced AMD. This telescope implant is a critical component of the CentraSight treatment program, which guides patients through the processes of diagnosis, surgical evaluation, and postoperative care. Founded in 1997, VisionCare is dedicated to helping patients reconnect with their daily lives and activities through its advanced visual prosthetic technologies.

Estech

Series D in 2010
Estech is a privately held medical device manufacturing and distribution company based in San Ramon, California. Founded in 1996 by Arthur and Raymond Bertolero, the company focuses on developing and marketing medical devices and disposables that facilitate both traditional and minimally invasive cardiac surgical procedures. Estech has established a global distribution network and is recognized for attracting skilled professionals in the medical device sector. The company's commitment to innovation and quality has enabled it to achieve sustained success in a competitive industry, reflecting the dedication of its team across all departments.

Laureate Pharma

Debt Financing in 2010
Laureate Pharma, Inc., a contract manufacturing organization, provides development and cGMP manufacturing services. It focuses on mammalian cell based monoclonal antibody and recombinant protein production for clinical and commercial supply. The company's biopharmaceutical production/biotherapeutics production services include cGMP production and purification, protein modification and conjugation, formulation and aseptic filling into vials and finishing, upstream and downstream process development, Cell Line Optimization, medium optimization studies and adapting cells to protein-free medium, pilot-scale bioreactor runs, and product formulation development. Its services also comprise transfection, cloning, and selection to create new cell lines; analytical method transfer, development, and qualification; and preclinical production, monoclonal antibody production, and clinical trials manufacturing. Laureate Pharma supports the development and commercialization of biopharmaceutical, drug, and diagnostic products for pharmaceutical, diagnostic, and biotech companies. The company was formerly known as Bard Biopharma L.P. and changed its name to Laureate Pharma, Inc. in 2002. The company is headquartered in Princeton, New Jersey.

Angi

Venture Round in 2010
Angi connects consumers with quality home service professionals across various sectors, including repairs, remodeling, cleaning, and landscaping. The company offers a range of services such as air duct cleaning, appliance repair, and architectural services, ensuring that professionals are vetted and reviews are verified to maintain quality. Angi operates through multiple brands, including Angi, HomeAdvisor, and Handy, and has three main segments: Ads and Leads, Services, and International, with a significant portion of its revenue generated in the United States. By providing reasonable prices and a reliable platform, Angi facilitates home projects and services for its users.

Incline Therapeutics

Series A in 2010
Incline Therapeutics is a privately-held specialty pharmaceutical company that focuses on the development of IONSYS, a fentanyl iontophoretic transdermal system designed for adult inpatients needing opioid pain relief following surgery. The company is dedicated to creating a compact, disposable, needleless Patient-Controlled Analgesia system that facilitates the short-term management of postoperative pain. Incline Therapeutics is backed by prominent life science venture capital firms and is led by a management team with extensive experience in the pharmaceutical and medical device sectors.

KXEN

Series D in 2010
KXEN, Inc. is a data mining automation company that specializes in business analytics software tailored for customer lifecycle analytics, supply chain analytics, and business intelligence. The company offers a range of software packages that facilitate various data manipulations, including classification, regression, and segmentation, as well as single-purpose analysis applications for forecasting and market basket analysis. KXEN's Analytic Framework integrates multiple components to provide comprehensive data mining automation solutions. In addition to its software offerings, KXEN provides technical support services, education programs, and consulting services to assist clients in utilizing their products effectively. The company primarily serves clients in the financial services, telecommunications, and retail sectors and distributes its products through systems integrators, software vendors, and original equipment manufacturers globally. Founded in 1998 and headquartered in San Francisco, KXEN has additional offices in Canada, the United Kingdom, and France, and maintains strategic partnerships with major technology firms.

MicroCHIPS

Venture Round in 2010
MicroCHIPS Biotech, Inc. specializes in developing a microchip-based implant designed for drug delivery applications across various therapeutic areas, including osteoporosis, diabetes, multiple sclerosis, women’s contraception, and pain management. This innovative implant can store and release precise doses of medication over extended periods, offering an alternative to traditional therapies that rely on frequent injections. The implant is surgically placed under the skin during a minimally invasive procedure and can be wirelessly activated or deactivated by healthcare providers or patients. Additionally, the device allows for real-time adjustments to the drug dosage and frequency, catering to the specific needs of each patient. Established in 1999 and headquartered in Lexington, Massachusetts, MicroCHIPS operates as a subsidiary of Daré Bioscience, Inc.

MediaKind

Debt Financing in 2009
Envivio is a prominent provider of software-based solutions for multi-screen video processing and delivery, enabling seamless access to video content across various devices and networks. With over a decade of experience, the company offers end-to-end video delivery products and services that enhance the capabilities of service providers, operators, content owners, and broadcasters. Envivio's solutions include video compression for both contribution and direct-to-consumer distribution, as well as cloud DVR and personalized advertising services. The company serves more than 300 clients globally, including leading mobile operators and broadband providers. Headquartered in South San Francisco, California, Envivio also maintains offices in several countries, including France, England, China, Singapore, and Japan.

Coapt Systems

Debt Financing in 2009
Coapt Systems, Inc. specializes in the design, development, and manufacturing of bio-absorbable implants intended for soft tissue fixation in facial cosmetic surgery. Its product offerings include various fixation devices such as the ENDOTINE Forehead 3.0 and ENDOTINE Midface ST 4.5, which are employed in procedures like forehead lifts, brow lifts, and midface suspensions. The company also provides surgical instruments and tools, including insertion kits and manual drills, to facilitate the use of its implants. Coapt Systems aims to support surgeons in achieving effective and secure tissue fixation during surgical procedures, enhancing outcomes for patients undergoing cosmetic interventions.

Actelis Networks

Venture Round in 2009
Actelis Networks, Inc. specializes in high-performance broadband solutions over copper, enabling the delivery of Ethernet and broadband access services. Founded in 1998 and headquartered in Fremont, California, the company offers a range of products, including aggregation switches, Ethernet access devices, and various broadband amplifiers. Its solutions cater to service operators and government customers, addressing needs in residential broadband, business Ethernet, small cell and Wi-Fi backhaul, as well as intelligent traffic systems and municipal networks. Actelis Networks effectively transforms copper infrastructure into a strategic asset, facilitating reliable and cost-effective connectivity for Internet of Things (IoT) projects across diverse environments such as cities, campuses, and military bases. The company emphasizes security in its networking solutions, ensuring protection for critical IoT data through advanced coding and encryption technologies. Actelis distributes its products via a network of resellers and maintains research and development facilities in Tel Aviv, alongside regional sales offices globally.

Estech

Venture Round in 2009
Estech is a privately held medical device manufacturing and distribution company based in San Ramon, California. Founded in 1996 by Arthur and Raymond Bertolero, the company focuses on developing and marketing medical devices and disposables that facilitate both traditional and minimally invasive cardiac surgical procedures. Estech has established a global distribution network and is recognized for attracting skilled professionals in the medical device sector. The company's commitment to innovation and quality has enabled it to achieve sustained success in a competitive industry, reflecting the dedication of its team across all departments.

Estech

Venture Round in 2008
Estech is a privately held medical device manufacturing and distribution company based in San Ramon, California. Founded in 1996 by Arthur and Raymond Bertolero, the company focuses on developing and marketing medical devices and disposables that facilitate both traditional and minimally invasive cardiac surgical procedures. Estech has established a global distribution network and is recognized for attracting skilled professionals in the medical device sector. The company's commitment to innovation and quality has enabled it to achieve sustained success in a competitive industry, reflecting the dedication of its team across all departments.

Broncus Medical

Series G in 2008
Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.

Arcadia Biosciences

Private Equity Round in 2008
Arcadia Biosciences, Inc. is an agricultural technology company based in Davis, California, focusing on the development of crop productivity traits primarily in hemp, wheat, and soybean. Established in 2002, the company employs advanced screening, breeding, and biotechnology techniques to create products that enhance farm economics and improve the value of crops as food ingredients, health and wellness products, and for industrial applications. Its product lineup includes GoodHemp, a range of non-GMO hemp seed varieties aimed at genetic improvement; GoodWheat, which transforms wheat into a functional food; and a drought and herbicide-tolerant soybean trait known as HB4. Additionally, Arcadia Biosciences produces plant-based food and beverage products, including high-fiber pasta and coconut water, thereby catering to consumer demands while promoting environmental sustainability. The company operates in diverse markets, including the United States, Canada, Africa, and India, and collaborates with several industry partners to advance its initiatives.

MediaKind

Venture Round in 2008
Envivio is a prominent provider of software-based solutions for multi-screen video processing and delivery, enabling seamless access to video content across various devices and networks. With over a decade of experience, the company offers end-to-end video delivery products and services that enhance the capabilities of service providers, operators, content owners, and broadcasters. Envivio's solutions include video compression for both contribution and direct-to-consumer distribution, as well as cloud DVR and personalized advertising services. The company serves more than 300 clients globally, including leading mobile operators and broadband providers. Headquartered in South San Francisco, California, Envivio also maintains offices in several countries, including France, England, China, Singapore, and Japan.

Alliance Consulting Group

Acquisition in 2008
Alliance Consulting Group is a Boston-based strategy consulting firm established in 1986. The firm specializes in providing a range of consulting services aimed at helping commercial clients grow their businesses. Their offerings include business process redesign, customer needs and segmentation analysis, innovation and new product development, market and competitive analysis, profit improvement, sales effectiveness, strategic planning, and sustainability strategies. Alliance Consulting Group focuses on delivering tailored solutions that align with the unique organizational requirements of their clients, ensuring exceptional value and fostering a collaborative environment for their staff.

LifeMasters Supported SelfCare

Venture Round in 2008
LifeMasters Supported SelfCare is a prominent disease management company that focuses on creating collaborative health partnerships between individuals, their healthcare providers, and payors. The company offers interactive disease management services designed to support individuals dealing with various chronic conditions, including diabetes, congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, hypertension, asthma, cancer, metabolic syndrome, and musculoskeletal pain. By providing decision support for healthcare providers, LifeMasters aims to enhance patient care while simultaneously reducing costs for payors. The company's programs and services are tailored to foster effective management of chronic diseases, ultimately promoting better health outcomes for individuals.

Zonare Medical Systems

Series G in 2007
Zonare Medical Systems, Inc. specializes in the development, manufacturing, and commercialization of compact ultrasound systems designed for diagnostic imaging across various clinical applications. The company's flagship product, the z.one ultrasound system, leverages its proprietary Zone Sonography technology, which facilitates advanced image processing and the integration of new clinical applications. Zonare Medical operates a direct sales model in the United States and utilizes a combination of distributors and direct sales personnel in approximately 40 international markets. Established in 1999 and headquartered in Mountain View, California, Zonare Medical was formerly known as NovaSonics, Inc. The company is recognized for its patented designs and architecture that provide high-quality imaging solutions with significant clinical versatility.

Blip

Series A in 2007
Blip is an online media platform that offers users access to a variety of video clips and programs focused on media and entertainment. The platform features content across multiple categories, including general entertainment, comedy, music, drama, television, food, and video games. It organizes its offerings into segments such as editors' picks, current trends, and new episodes. Additionally, Blip provides producers with tools to host, distribute, and monetize their web series. Founded in 2005 by Charles Hope and Jared Klett, Blip is headquartered in New York City.

SideStep

Series C in 2007
SideStep is a metasearch engine designed to assist travelers by searching over 200 travel websites to find the best deals on flights, hotels, and other travel-related services. The company generates revenue through advertising and referral fees. SideStep has expanded its offerings by acquiring TripUp, a social network focused on travel, and TravelPost.com, a hotel ratings site, aiming to become a leading source of online travel information. Additionally, SideStep has developed Facebook applications such as Trips, which offers trip planning services with over 150,000 users, and Extended Info, allowing users to customize their Facebook profiles. The company was acquired by Kayak in December 2007 for approximately $180 million.

Forte Design Systems

Series D in 2006
Forte Design Systems, Inc. is a software provider specializing in semiconductor design solutions. Founded in 2001 and headquartered in San Jose, California, with additional offices in various U.S. states and internationally in France and Japan, the company offers Cynthesizer, a silicon-proven behavioral synthesis technology that generates production-quality RTL. This innovative technology enables design teams to develop complex electronic systems from algorithmic designs using ASICs, FPGAs, and SoCs, effectively reducing design and verification time. Forte's products cater to a range of industries, including consumer electronics, digital media, wireless communications, and security. The company maintains a direct sales presence in North America, Europe, and Japan, and has established value-added reseller partnerships in Korea.

Seven Networks

Venture Round in 2006
SEVEN Networks, Inc. is a software company that specializes in device-centric mobile traffic management and analytics for wireless carriers globally. Founded in 2000 and headquartered in San Carlos, California, SEVEN Networks offers a range of products, including its Open Channel software line, which enhances mobile traffic visibility and optimization while improving end-user experiences. The company's mobile applications facilitate social messaging for consumers and provide carriers with tools for effective communication across various platforms. Additionally, SEVEN’s Push Technology and Notifications reduce network traffic and increase user engagement with mobile services. The company also provides technical support and professional services, including solution integration and device management. With a robust portfolio of over three hundred patents and extensive industry recognition, SEVEN Networks is noted for its innovations in mobile traffic management and analytics, making it a leader in optimizing wireless infrastructure.

PatientKeeper

Series E in 2006
PatientKeeper specializes in EHR optimization software that enhances clinical and revenue cycle workflows for healthcare providers, care teams, billers, and coders. Its solutions enable healthcare professionals to efficiently manage patient data, access clinical results, enter diagnoses and billing information, dictate notes, and write prescriptions. By serving as a system of engagement alongside existing EHR systems, PatientKeeper allows providers to seamlessly access and act on patient information using smartphones, tablets, and PCs, ultimately improving patient care and operational performance.

Novera Optics

Venture Round in 2006
Novera Optics specializes in developing optical access solutions aimed at enhancing connectivity in various markets. The company's offerings include PON optical solutions, which cater to equipment vendors and service providers dealing with fiber-to-the-building, fiber-to-the-curb extensions, and multi-dwelling units. Novera Optics also provides Wavelength Division Multiplexed-Passive Optical Networks (WDM-PON), an integrated access and transport platform that facilitates the delivery of voice, data, video, and wireless services. By focusing on fiber-optic technology, Novera Optics addresses bandwidth limitations in copper-based last-mile networks, enabling high-speed carrier Ethernet services to reach customer premises efficiently.

Vua Ke Sat

Series E in 2005
NextWeb is a wireless Internet service provider, providing high-speed service to more than 1000 enterprise customers in Northern and Southern California. NextWeb's service is available in over 50,000 business locations in more than 60 cities. Typically installed in just three to seven days, NextWeb's service is 30 percent faster than a T1 at approximately half the cost, easily scaling to six times the speed of a T1.

MetaTV

Series B in 2001
MetaTV was founded in 1999 to define technology and services which would forever change the way people look at television.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.